Concepedia

Gary C. Doolittle

GC

Statistics

Publications

45

Citations

2.5K

H-Index

26

Active since

1989

Affiliations

University of Kansas Medical Center(Current)

University of Kansas

Michigan State University

The University of Kansas Cancer Center

The University of Texas MD Anderson Cancer Center

Gary C. Doolittle is an author at University of Kansas Medical Center specializing in medicine, nursing, and telehealth.

ORCID

Top concepts

Publications per year

1989–2023

45

Publications

45

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel, Megan Othus, Yuanbin Chen et al. · New England Journal of Medicine · 2023 · 741 citations · Full text

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio, Karl D. Lewis, Lev Demidov et al. · The Lancet Oncology · 2018 · 210 citations · Full text

, , +10

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial

Alain P. Algazi, Megan Othus, Adil Daud et al. · Nature Medicine · 2020 · 108 citations · Full text

, , +9

Providing Access to Oncology Care for Rural Patients via Telemedicine

Gary C. Doolittle, Ashley Spaulding · Journal of Oncology Practice · 2006 · 94 citations · Full text

, , +30

Telehealth Services to Improve Nonadherence: A Placebo-Controlled Study

Carol E. Smith, Emily R. Dauz, Faye Clements et al. · Telemedicine Journal and e-Health · 2006 · 92 citations · Full text

1–5 of 45